Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.
Durante C, Tognini S, Montesano T, Orlandi F, Torlontano M, Puxeddu E, Attard M, Costante G, Tumino S, Meringolo D, Bruno R, Trulli F, Toteda M, Redler A, Ronga G, Filetti S, Monzani F; PTC Study Group. Durante C, et al. Among authors: puxeddu e. Thyroid. 2014 Jul;24(7):1139-45. doi: 10.1089/thy.2013.0698. Epub 2014 May 21. Thyroid. 2014. PMID: 24702238 Free PMC article.
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, Barbi F, Avenia N, Scipioni A, Verrienti A, Tosi E, Cavaliere A, Gulino A, Filetti S, Russo D. Durante C, et al. Among authors: puxeddu e. J Clin Endocrinol Metab. 2007 Jul;92(7):2840-3. doi: 10.1210/jc.2006-2707. Epub 2007 May 8. J Clin Endocrinol Metab. 2007. PMID: 17488796
Clinical implications of BRAF mutation in thyroid carcinoma.
Puxeddu E, Durante C, Avenia N, Filetti S, Russo D. Puxeddu E, et al. Trends Endocrinol Metab. 2008 May-Jun;19(4):138-45. doi: 10.1016/j.tem.2007.12.003. Epub 2008 Mar 11. Trends Endocrinol Metab. 2008. PMID: 18337114 Review.
Targeted molecular therapies in thyroid carcinoma.
Romagnoli S, Moretti S, Voce P, Puxeddu E. Romagnoli S, et al. Among authors: puxeddu e. Arq Bras Endocrinol Metabol. 2009 Dec;53(9):1061-73. doi: 10.1590/s0004-27302009000900002. Arq Bras Endocrinol Metabol. 2009. PMID: 20126863 Review.
Targeted therapies for advanced thyroid cancer.
Puxeddu E, Romagnoli S, Dottorini ME. Puxeddu E, et al. Curr Opin Oncol. 2011 Jan;23(1):13-21. doi: 10.1097/CCO.0b013e328340cf94. Curr Opin Oncol. 2011. PMID: 21045687 Review.
Epigenetics of thyroid cancer and novel therapeutic targets.
Russo D, Damante G, Puxeddu E, Durante C, Filetti S. Russo D, et al. Among authors: puxeddu e. J Mol Endocrinol. 2011 Apr 28;46(3):R73-81. doi: 10.1530/JME-10-0150. Print 2011 Jun. J Mol Endocrinol. 2011. PMID: 21325372 Review.
178 results